Bangladesh · Delayed Price · Currency is BDT Pharma Aids Statistics
Total Valuation
Pharma Aids has a market cap or net worth of BDT 1.67 billion. The enterprise value is 1.65 billion.
| Market Cap | 1.67B |
| Enterprise Value | 1.65B |
Important Dates
The next estimated earnings date is Thursday, April 30, 2026.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | Dec 8, 2025 |
Share Statistics
Pharma Aids has 3.12 million shares outstanding.
| Current Share Class | 3.12M |
| Shares Outstanding | 3.12M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 18.78% |
| Owned by Institutions (%) | n/a |
| Float | 2.53M |
Valuation Ratios
The trailing PE ratio is 23.07.
| PE Ratio | 23.07 |
| Forward PE | n/a |
| PS Ratio | 3.52 |
| PB Ratio | 3.58 |
| P/TBV Ratio | 3.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 29.89 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.77, with an EV/FCF ratio of -1,844.40.
| EV / Earnings | 22.75 |
| EV / Sales | 3.47 |
| EV / EBITDA | 15.77 |
| EV / EBIT | 17.13 |
| EV / FCF | -1,844.40 |
Financial Position
The company has a current ratio of 2.94, with a Debt / Equity ratio of 0.04.
| Current Ratio | 2.94 |
| Quick Ratio | 1.43 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.16 |
| Debt / FCF | -18.79 |
| Interest Coverage | 39.50 |
Financial Efficiency
Return on equity (ROE) is 16.65% and return on invested capital (ROIC) is 16.92%.
| Return on Equity (ROE) | 16.65% |
| Return on Assets (ROA) | 9.84% |
| Return on Invested Capital (ROIC) | 16.92% |
| Return on Capital Employed (ROCE) | 20.51% |
| Weighted Average Cost of Capital (WACC) | 4.35% |
| Revenue Per Employee | 5.05M |
| Profits Per Employee | 770,873 |
| Employee Count | 94 |
| Asset Turnover | 0.78 |
| Inventory Turnover | 4.36 |
Taxes
In the past 12 months, Pharma Aids has paid 21.47 million in taxes.
| Income Tax | 21.47M |
| Effective Tax Rate | 22.86% |
Stock Price Statistics
The stock price has decreased by -2.81% in the last 52 weeks. The beta is 0.01, so Pharma Aids's price volatility has been lower than the market average.
| Beta (5Y) | 0.01 |
| 52-Week Price Change | -2.81% |
| 50-Day Moving Average | 548.19 |
| 200-Day Moving Average | 554.07 |
| Relative Strength Index (RSI) | 45.37 |
| Average Volume (20 Days) | 7,217 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Pharma Aids had revenue of BDT 474.48 million and earned 72.46 million in profits. Earnings per share was 23.23.
| Revenue | 474.48M |
| Gross Profit | 146.77M |
| Operating Income | 96.24M |
| Pretax Income | 93.93M |
| Net Income | 72.46M |
| EBITDA | 104.53M |
| EBIT | 96.24M |
| Earnings Per Share (EPS) | 23.23 |
Balance Sheet
The company has 40.24 million in cash and 16.80 million in debt, with a net cash position of 23.45 million or 7.51 per share.
| Cash & Cash Equivalents | 40.24M |
| Total Debt | 16.80M |
| Net Cash | 23.45M |
| Net Cash Per Share | 7.51 |
| Equity (Book Value) | 466.57M |
| Book Value Per Share | 149.54 |
| Working Capital | 326.22M |
Cash Flow
In the last 12 months, operating cash flow was 55.93 million and capital expenditures -56.83 million, giving a free cash flow of -893,819.
| Operating Cash Flow | 55.93M |
| Capital Expenditures | -56.83M |
| Depreciation & Amortization | 8.29M |
| Net Borrowing | 16.49M |
| Free Cash Flow | -893,819 |
| FCF Per Share | -0.29 |
Margins
Gross margin is 30.93%, with operating and profit margins of 20.28% and 15.27%.
| Gross Margin | 30.93% |
| Operating Margin | 20.28% |
| Pretax Margin | 19.80% |
| Profit Margin | 15.27% |
| EBITDA Margin | 22.03% |
| EBIT Margin | 20.28% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 3.00, which amounts to a dividend yield of 0.56%.
| Dividend Per Share | 3.00 |
| Dividend Yield | 0.56% |
| Dividend Growth (YoY) | 20.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 12.92% |
| Buyback Yield | n/a |
| Shareholder Yield | 0.56% |
| Earnings Yield | 4.33% |
| FCF Yield | -0.05% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 4, 2011. It was a forward split with a ratio of 10.
| Last Split Date | Dec 4, 2011 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
Pharma Aids has an Altman Z-Score of 8.72 and a Piotroski F-Score of 5.
| Altman Z-Score | 8.72 |
| Piotroski F-Score | 5 |